Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 27;12(10):1520.
doi: 10.3390/genes12101520.

Fanconi Anaemia, Childhood Cancer and the BRCA Genes

Emma R Woodward  1   2   3 , Stefan Meyer  3   4   5   6
Affiliations
Review

Fanconi Anaemia, Childhood Cancer and the BRCA Genes

Emma R Woodward et al. Genes (Basel). .

Abstract

Fanconi anaemia (FA) is an inherited chromosomal instability disorder characterised by congenital and developmental abnormalities and a strong cancer predisposition. In less than 5% of cases FA can be caused by bi-allelic pathogenic variants (PGVs) in BRCA2/FANCD1 and in very rare cases by bi-allelic PGVs in BRCA1/FANCS. The rarity of FA-like presentation due to PGVs in BRCA2 and even more due to PGVs in BRCA1 supports a fundamental role of the encoded proteins for normal development and prevention of malignant transformation. While FA caused by BRCA1/2 PGVs is strongly associated with distinct spectra of embryonal childhood cancers and AML with BRCA2-PGVs, and also early epithelial cancers with BRCA1 PGVs, germline variants in the BRCA1/2 genes have also been identified in non-FA childhood malignancies, and thereby implying the possibility of a role of BRCA PGVs also for non-syndromic cancer predisposition in children. We provide a concise review of aspects of the clinical and genetic features of BRCA1/2-associated FA with a focus on associated malignancies, and review novel aspects of the role of germline BRCA2 and BRCA1 PGVs occurring in non-FA childhood cancer and discuss aspects of clinical and biological implications.

Keywords: BRCA1; BRCA2; childhood cancer; fanconi anaemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Common and diverse clinical and cellular aspects of bi-allelic pathogenic variants in BRCA1 and BRCA2.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Schneider M., Chandler K., Tischkowitz M., Meyer S. Fanconi anaemia: Genetics, molecular biology, and cancer-implications for clinical management in children and adults. Clin. Genet. 2015;88:13–24. doi: 10.1111/cge.12517. - DOI - PubMed
    1. Taylor A.M.R., Rothblum-Oviatt C., Ellis N.A., Hickson I.D., Meyer S., Crawford T.O., Smogorzewska A., Pietrucha B., Weemaes C., Stewart G.S. Chromosome instability syndromes. Nat. Rev. Dis. Primers. 2019;5:64. doi: 10.1038/s41572-019-0113-0. - DOI - PubMed
    1. Huck K., Hanenberg H., Gudowius S., Fenk R., Kalb R., Neveling K., Betz B., Niederacher D., Haas R., Gobel U., et al. Delayed diagnosis and complications of Fanconi anaemia at advanced age—A paradigm. Br. J. Haematol. 2006;133:188–197. doi: 10.1111/j.1365-2141.2006.05998.x. - DOI - PubMed
    1. Neveling K., Endt D., Hoehn H., Schindler D. Genotype-phenotype correlations in Fanconi anemia. Mutat. Res. 2009;668:73–91. doi: 10.1016/j.mrfmmm.2009.05.006. - DOI - PubMed
    1. Fiesco-Roa M.O., Giri N., McReynolds L.J., Best A.F., Alter B.P. Genotype-phenotype associations in Fanconi anemia: A literature review. Blood Rev. 2019;37:100589. doi: 10.1016/j.blre.2019.100589. - DOI - PMC - PubMed

Publication types